STAT3 upregulation of miR21 has been documented in breast cancer [18], nasopharyngeal carcinoma [52], and hepatocellular cancer [53], and now shown in the present study relating to lung derived BMs. This evidence concerns the gene STAT3 and breast carcinoma.